NCT04704661 2026-03-18Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialNational Cancer Institute (NCI)Phase 1 Recruiting51 enrolled